Skip to main content

Month: August 2020

Acura Pharmaceuticals Announces Second Quarter 2020 Financial Results

PALATINE, Ill., Aug. 14, 2020 (GLOBE NEWSWIRE) — Acura Pharmaceuticals, Inc. (OTCQB: ACUR), a specialty pharmaceutical company engaged in the research, development and commercialization of technologies and product candidates intended to mitigate the risk of outcomes associated with product misuse, announced today financial results for the three and six months ended June 30, 2020.The Company reported revenues of $1.4 million and an operating income of $421 thousand for the second quarter 2020 compared to revenues of only $46 thousand and an operating loss of $622 thousand for the same period in 2019.  For the six months ended June 30, 2020, the Company reported revenues of $2.4 million and an operating loss of $62 thousand compared to revenues of only $113 thousand and an operating loss of $1.3 million for the same period in 2019. ...

Continue reading

U.S. Energy Corp. Announces Second Quarter Financial and Operating Results

HOUSTON, Aug. 14, 2020 (GLOBE NEWSWIRE) — U.S. Energy Corp. (NASDAQCM: USEG) (“We”, “U.S. Energy” or the “Company”) today announced financial and operating results for the second quarter ended June 30, 2020. Management Comments“Despite the continuation of the challenging commodity price backdrop and unprecedented shut-in activity taking place across large portions of the upstream industry, U.S. Energy is uniquely well positioned to take advantage of the turmoil in the commodity markets,” said Ryan Smith, U.S. Energy’s Chief Executive Officer. “While we were undoubtedly affected by shut-in activity and low prices, our low-cost corporate structure and strong balance sheet have enabled us to weather the storm and continue pursuing our stated strategy of acquiring PDP heavy assets that are immediately cash flow accretive. With the recent...

Continue reading

U.S. FDA Advisory Committee Votes Nine to One in Favor of Remestemcel-L (Ryoncil™) for Efficacy in Children With Steroid-Refractory Acute Graft Versus Host Disease

NEW YORK, Aug. 14, 2020 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in cellular medicines for inflammatory diseases, today announced that the Oncologic Drugs Advisory Committee (ODAC) of the United States Food and Drug Administration (FDA) voted overwhelmingly in favor that the available data support the efficacy of remestemcel-L (RYONCIL™) in pediatric patients with steroid-refractory acute graft versus host disease (SR-aGVHD).Mesoblast Chief Medical Officer Dr Fred Grossman said: “Steroid-refractory acute graft versus host disease is an area of extreme need, especially in vulnerable children under 12 years old where there is no approved therapy. We are very encouraged by today’s outcome and are committed to working closely with the FDA as they complete their review of our submission regarding approval...

Continue reading

SERSTECH AB: Serstech receives EU funding for CBRN project

A consortium of public and private organizations, of which Serstech is part, has been granted funding from the European Commission. The project aims to develop technologies, based on Raman and SERS (Surface Enhanced Raman Spectroscopy), to detect and identify chemical warfare agents and toxic industrial compounds in liquid and gas form. Serstech will supply modified Raman devices as part of the project.In August, Serstech will receive the initial payment of approximately 2 MSEK and will receive another 2 MSEK over the project period, which extends over three and a half years. The consortium includes several European universities and the Swedish Defence Research Agency (FOI).The project aims to provide a solution for first responders and CBRN (Chemical, Biological, Radiological, Nuclear) specialists to detect hazards in their everyday...

Continue reading

Aspo Oyj:n omien osakkeiden luovutus

Aspo Oyj                       Pörssitiedote                      14.8.2020 klo 13.00Aspo Oyj on luovuttanut 5 000 kpl yhtiön hallussa olevaa omaa osaketta vuoden 2020 Sitouttavan osakepalkkiojärjestelmän perusteella. Luovutus perustuu varsinaisen yhtiökokouksen 4.5.2020 antamaan osakeantivaltuutukseen. Osakkeet on luovutettu osakepalkkiojärjestelmän ehtojen mukaisesti vastikkeetta.Aspo on monialayhtiö, joka omistaa ja kehittää liiketoimintoja Pohjois-Euroopan lisäksi kasvumarkkinoilla keskittyen vaativiin B-to-B -asiakkaisiin. Vahvojen yritysbrändien, ESL Shipping, Leipurin, Telko ja Kauko, tavoitteena on olla toimialojensa markkinajohtajia. Ne vastaavat omasta toiminnastaan, asiakassuhteistaan ja niiden kehittämisestä. Kokonaisuutena ne tuottavat Aspon liikearvon. Aspon konsernirakennetta ja liiketoimintoja kehitetään pitkäjänteisesti...

Continue reading

Combined Annual General Meeting of April 2020

Press release – Paris- 04/09/2020The Convening Notice that will be published in the Balo (Bulletin des Annonces Légales Obligatoires) on 19 August 2020 contains the agenda of the Ordinary General Meeting of 4 September 2020 and sets out the arrangements for participating and voting in the Ordinary General Meeting. The Notice of Meeting containing the draft resolutions submitted by the Board of Directors was published in the Balo on 31 July 2020.All of the documents and information relating to the General Meeting, as well as the postal and proxy vote forms are available on the company’s website at:www.bouygues.comunder Finance/Individual shareholders/Annual General Meeting.Shareholders may, in accordance with the conditions and time limits specified in Article R. 225-88 of the French Commercial Code, ask that the documents and information...

Continue reading

modalités de mise à disposition ou de consultation des documents préparatoires à l’assemblée générale

Communiqué de presse – Paris – 14/08/2020Assemblée générale mixte du 4 septembre 2020Modalités de mise à disposition ou consultation des documents préparatoires à l’assemblée généraleL’avis de convocation qui sera publié au BALO (Bulletin des Annonces Légales Obligatoires) du 19 août 2020 contient l’ordre du jour de l’assemblée générale ordinaire du 4 septembre 2020 et décrit les modalités de participation et de vote à l’assemblée et d’exercice des droits des actionnaires. L’avis de réunion, contenant le texte des projets de résolutions présentés par le conseil d’administration a été publié au BALO du 31 juillet 2020.Tous les documents et informations relatifs à l’assemblée générale ainsi que les formulaires de vote par correspondance ou par procuration sont en ligne sur le site internet de la société :www.bouygues.comTout actionnaire...

Continue reading

First Marketing Campaign with Alfa Romeo Racing ORLEN Featuring ConceptD Goes Live Today

Bioggio, Switzerland, Aug. 14, 2020 (GLOBE NEWSWIRE) — Acer announced the next steps in its partnership with Alfa Romeo Racing ORLEN.As official partners, Acer and Alfa Romeo Racing ORLEN also worked  together to create engaging and compelling content for social mediaand other digital campaigns. Acer is set to launch a new campaign targeted at users of design and simulation in engineering and manufacturing applications under the theme“Designed to Race” featuring its ConceptD solutions including stationary and mobile workstations and Monitors. The second campaign set to be released in the coming weeks focuses on Acer’s ENDURO ruggedized PCs “BUILT FOR EXTREME”.  “Acer has created an incredibly engaging marketing and activation strategy around our partnership and the whole Alfa Romeo Racing ORLEN team,”says Frédéric Vasseur, Team...

Continue reading

Enstar and Stone Point Capital Announce Exchange Transaction Involving Atrium and StarStone U.S.

HAMILTON, Bermuda, Aug. 14, 2020 (GLOBE NEWSWIRE) — Enstar Group Limited (NASDAQ: ESGR) (“Enstar”) today announced an exchange agreement with Trident V, L.P. and its affiliated funds (the “Trident V Funds”) managed by Stone Point Capital LLC (“Stone Point”). Subject to regulatory approvals, the transaction will result in Enstar owning a greater share in StarStone U.S. Holdings, Inc. (“StarStone U.S.”) and the Trident V Funds owning a greater share in the holding company for Atrium Underwriting Group Limited (“Atrium”).The transaction is conditioned upon the closing of the previously announced recapitalization of StarStone U.S., pursuant to which a new management team and Board of Directors will be appointed and new investors will be brought in to increase its total equity capitalization to over $850 million, with an Enstar subsidiary...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.